ECE-1: A membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1

Cell

Volumn 78, Issue 3, 1994, Pages 473-485

  Xu, Dong ^a   Emoto, Noriaki ^a   Giaid, Adel ^b   Slaughter, Clive ^a   Kaw, Semiko ^a   deWit, Damiane ^a   Yanagisawa, Masashi ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b MONTREAL GENERAL HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; ENDOTHELIN 1; MEMBRANE METALLOENDOPEPTIDASE; METALLOPROTEINASE;

ARTICLE; CELL INTERACTION; CELL SURFACE; ENDOTHELIUM CELL; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME MECHANISM; GENETIC TRANSFECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; TISSUE DISTRIBUTION; VASCULAR ENDOTHELIUM;

EID: 0027992642     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/0092-8674(94)90425-1     Document Type: Article

References (48)

1. The endothelin-converting enzyme from human umbilical vein is a membrane-bound metalloprotease similar to that from bovine aortic endothelial cells
2. Cloning and expression of a cDNA encoding an endothelin receptor
3. A specific endothelin subtype A receptor antagonist protects against injury in renal disease progression
4. Acute cyclosporine-induced renal vasoconstriction is mediated by endothelin-1
5. High-efficiency transformation of mammalian cells by plasmid DNA
6. Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist
7. Internal protein sequence analysis enzymatic digestion for less than 10 μg of protein bound to polyvinylidene difluoride or nitrocellulose membranes
8. A receptor antagonist in the rat
9. Topographical localisation of endothelin mRNA and peptide immunoreactivity in neurons of the human brain
10. Expression of endothelin-1 in lungs of patients with pulmonary hypertension
11. The endothelin-1 receptor antagonist BQ-123 reduces infarct size in a canine model of coronary occlusion and reperfusion
12. Concomitant expression of receptor subtype and isopeptide of endothelin by human adrenal gland
13. The human endothelin family three structurally and pharmacologically distinct isopeptides predicted by three separate genes
14. The human preproendothelin-1 gene
15. Endothelin-1 is an autocrine/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes
16. A receptor antagonist, BQ-485, and its preventive effect on experimental cerebral vasospasm in dogs
17. Effects of BQ-123 on renal function and acute cyclosporine-induced renal dysfunction
18. Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1
19. Cloning of the GATA-binding protein that regulates endothelin-1 gene expression in endothelial cells
20. Molecular cloning and primary structure of Kell blood group protein
21. Molecular cloning and amino acid sequence of human enkephalinase (neutral endopeptidase)
22. Phosphoramidon blocks the pressor activity of porcine big endothelin-1(139) in vivo and conversion of big endothelin-1(139) to endothelin-1(121) in vitro
23. Synthesis of endothelin-1 analogues endothelin-3 and sarafotoxin S6b structure-activity relationships
24. Antihypertensive effect of a newly synthesized endothelin antagonist BQ-123 in a genetic hypertensive model
25. Receptor binding affinity and biological activity of C-terminal elongated forms of endothelin-1
26. SB 209670, a rationally designed potent nonpeptide endothelin receptor antagonist
27. Purification and characterization of a phosphoramidonsensitive endothelin-converting enzyme in porcine aortic endothelium
28. Big endothelin-1 structure important for specific processing by endothelin-converting enzyme of bovine endothelial cells
29. Endothelin-converting enzymes
30. Evolutionary families of peptidases
31. Neutral endopeptidase 2411 structure inhibition and experimental and clinical pharmacology
32. Endothelial cells stimulate aldosterone release from bovine adrenal zona glomerulosa cells
33. B-selective agaonists
34. Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor
35. Phosphoramidon inhibits the intracellular conversion of big endothelin-1 to endothelin-1 in cultured endothelial cells
36. Mammalian paired basic amino acid convertases of prohormones and proproteins
37. A receptor antagonist
38. A antagonist 5-(dimethylamino)-N-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide
39. A sandwich-type enzyme immunoassay to detect immunoreactive big-endothelin-1 in plasma
40. Purification and characterization of endothelin-converting enzyme from rat lung
41. WS79089A B and C new endothelin converting enzyme inhibitors isolated from Streptosporangium roseum NO 79089
42. Endothelin-converting enzymes and other families of metallo-endopeptidases
43. Messenger RNA expression and synthesis of endothelin-1 along rat nephron segments
44. Secretory functions of the vascular endothelium
45. The hydrolysis of endothelins by neutral endopeptidase 2411 (enkephalinase)
46. Identification and characterization of endothelin converting activity from EAHY 926 cells evidence for the physiologically relevant human enzymes
47. The endothelin system a new target for therapeutic intervention
48. A novel potent vasoconstrictor peptide produced by vascular endothelial cells